Search Results - "COLD, Søren"

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study by Cold, Søren, Cold, Frederik, Jensen, Maj-Britt, Cronin-Fenton, Deirdre, Christiansen, Peer, Ejlertsen, Bent

“…Women treated for breast cancer (BC) often suffer genitourinary syndrome of menopause. These symptoms may be alleviated by vaginal estrogen therapy (VET) or…”
Get full text

Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial by Rayman, Margaret P., Winther, Kristian Hillert, Pastor-Barriuso, Roberto, Cold, Frederick, Thvilum, Marianne, Stranges, Saverio, Guallar, Eliseo, Cold, Søren

“…Selenium, an essential trace element, is incorporated into selenoproteins with a wide range of health effects. Selenoproteins may reach repletion at a plasma…”
Get full text

Response to Van Cauwenberge, Borremans, Van Houdt, et al by Cold, Søren, Jensen, Maj-Britt, Ejlertsen, Bent

Get full text

Effect of Obesity on Prognosis After Early-Stage Breast Cancer by EWERTZ, Marianne, JENSEN, Maj-Britt, GUNNARSDOTTIR, Katrín A, HØJRIS, Inger, JAKOBSEN, Erik H, NIELSEN, Dorte, STENBYGAARD, Lars E, TANGE, Ulla B, COLD, Søren

“…This study was performed to characterize the impact of obesity on the risk of breast cancer recurrence and death as a result of breast cancer or other causes…”
Get full text

Response to Pederson et al. and Chlebowski et al by Cold, Søren, Cold, Frederik, Jensen, Maj-Britt, Cronin-Fenton, Deirdre, Christiansen, Peer, Ejlertsen, Bent

Get full text

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study by Kodahl, Annette R., Lyng, Maria B., Binder, Harald, Cold, Søren, Gravgaard, Karina, Knoop, Ann S., Ditzel, Henrik J.

“…There are currently no highly sensitive and specific minimally invasive biomarkers for detection of early-stage breast cancer. MicroRNAs (miRNAs) are present…”
Get full text

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial by Chan, Arlene, Moy, Beverly, Mansi, Janine, Ejlertsen, Bent, Holmes, Frankie Ann, Chia, Stephen, Iwata, Hiroji, Gnant, Michael, Loibl, Sibylle, Barrios, Carlos H., Somali, Isil, Smichkoska, Snezhana, Martinez, Noelia, Alonso, Mirta Garcia, Link, John S., Mayer, Ingrid A., Cold, Søren, Murillo, Serafin Morales, Senecal, Francis, Inoue, Kenichi, Ruiz-Borrego, Manuel, Hui, Rina, Denduluri, Neelima, Patt, Debra, Rugo, Hope S., Johnston, Stephen R.D., Bryce, Richard, Zhang, Bo, Xu, Feng, Wong, Alvin, Martin, Miguel

“…The ExteNET trial demonstrated improved invasive disease-free survival (iDFS) with neratinib, an irreversible pan-HER tyrosine kinase inhibitor, versus placebo…”
Get full text

Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population by Winther, Kristian Hillert, Bonnema, Steen Joop, Cold, Frederik, Debrabant, Birgit, Nybo, Mads, Cold, Søren, Hegedüs, Laszlo

“…ObjectiveSelenium is present in the active site of proteins important for thyroid hormone synthesis and metabolism. The objective of this study is to…”
Get full text

Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer by Sørensen, Kristina P., Thomassen, Mads, Tan, Qihua, Bak, Martin, Cold, Søren, Burton, Mark, Larsen, Martin J., Kruse, Torben A.

“…Expression of HOX transcript antisense intergenic RNA ( HOTAIR )—a long non-coding RNA—has been examined in a variety of human cancers, and overexpression of…”
Get full text

Translation and cultural adaptation of the Communication Assessment Tool (CAT), developing a Danish and Norwegian version by Iversen, Else Dalsgaard, Steinsbekk, Aslak, Falbe Vind, Birgitte, Bangsgaard, Annemarie, Cold, Søren, Ammentorp, Jette

“…To translate and cultural adapt the 14-item Communication Assessment Tool (CAT) into Norwegian and Danish, making them as similar as possible. This was a…”
Get full text

Treatment of advanced HR+/HER2- breast cancer with new targeted agents in combination with endocrine therapy: a review of efficacy and tolerability based on available randomized trials on everolimus, ribociclib, palbociclib and abemaciclib by Bøttcher, Tea M, Cold, Søren, Jensen, Anders B

“…Recently, new targeted agents have been developed, which can prolong the effect of endocrine treatment (ET) by targeting resistance pathways in HR+/HER2-…”
Get more information

Neoadjuvant chemotherapy for primary operable breast cancer by Halberg, Anne Krag, Gravesen, Charlotte Dahl, Cold, Søren, Jensen, Jeanette Dupont

“…INTRODUCTIONNeoadjuvant chemotherapy (NACT) has been found useful in downstaging tumours in women with primary operable breast cancer without increasing…”
Get full text

Codebook for rating clinical communication skills based on the Calgary-Cambridge Guide by Iversen, Else Dalsgaard, Wolderslund, Maiken Overbeck, Kofoed, Poul-Erik, Gulbrandsen, Pål, Poulsen, Helle, Cold, Søren, Ammentorp, Jette

“…The aim of the study was to confirm the validity and reliability of the Observation Scheme-12, a measurement tool for rating clinical communication skills. The…”
Get full text

Effect of selenium supplementation on changes in HbA1c: Results from a multiple‐dose, randomized controlled trial by Stranges, Saverio, Rayman, Margaret P., Winther, Kristian H., Guallar, Eliseo, Cold, Søren, Pastor‐Barriuso, Roberto

“…Aim To investigate the effect of selenium supplementation at different dose levels on changes in HbA1c after 6 months and 2 years in a population of low…”
Get full text

Long‐Term Selenium‐Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo‐Controlled Trial by Perri, Giorgia, Hill, Tom R, Mathers, John C, Walsh, Jennifer S, Gossiel, Fatma, Winther, Kristian, Frölich, Jacob, Folkestad, Lars, Cold, Søren, Eastell, Richard

“…ABSTRACT Higher selenium status has been associated with lower bone turnover markers (BTM) in epidemiological studies. However, the long‐term impact of…”
Get full text

Communication Skills Training: A Means to Promote Time-Efficient Patient-Centered Communication in Clinical Practice by Iversen, Else Dalsgaard, Wolderslund, Maiken, Kofoed, Poul-Erik, Gulbrandsen, Pål, Poulsen, Helle, Cold, Søren, Ammentorp, Jette

“…We hypothesized that health care providers would behave in a more patient-centered manner after the implementation of communication skills training, without…”
Get full text

Randomised controlled trial of the effect of long-term selenium supplementation on plasma cholesterol in an elderly Danish population by Cold, Frederik, Winther, Kristian H., Pastor-Barriuso, Roberto, Rayman, Margaret P., Guallar, Eliseo, Nybo, Mads, Griffin, Bruce A., Stranges, Saverio, Cold, Søren

“…Although cross-sectional studies have shown a positive association between Se and cholesterol concentrations, a recent randomised controlled trial in 501…”
Get full text

Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients by Banke, Ann, Schou, Morten, Ewertz, Marianne, Dahl, Jordi, Frederiksen, Peter Hartmund, Videbæk, Lars, Cold, Søren, Møller, Jacob E.

“…Background Global longitudinal strain (GLS) is recommended to detect subclinical changes preceding reduced left ventricular ejection fraction (LVEF) in…”
Get full text

Ensemble‐based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long‐term risk of metastases by Block, Ines, Burton, Mark, Sørensen, Kristina P., Larsen, Martin J., Do, Thi T. N., Bak, Martin, Cold, Søren, Thomassen, Mads, Tan, Qihua, Kruse, Torben A.

“…Background Current clinical markers overestimate the recurrence risk in many lymph node negative (LNN) breast cancer (BC) patients such that a majority of…”
Get full text

Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab by Banke, Ann, Fosbøl, Emil L., Ewertz, Marianne, Videbæk, Lars, Dahl, Jordi S., Poulsen, Mikael Kjær, Cold, Søren, Jensen, Maj-Britt, Gislason, Gunnar H., Schou, Morten, Møller, Jacob E.

“…This study sought to evaluate the long-term risk of developing heart failure (HF) in patients receiving trastuzumab therapy. Trastuzumab has improved the…”
Get full text